Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Pediatric Refractory Solid Tumors
NCT01751308Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2013
- Primary completion
- Jul 2015
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in solid tumor, high-grade glioma (HGG), diffuse intrinsic pontine glioma (DIPG), sponsored by Sanofi. Started Feb 2013; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
solid tumorhigh-grade glioma (HGG)diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT01751308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01751308.